Welcome to our dedicated page for JPMorgan Chase & news (Ticker: JPM), a resource for investors and traders seeking the latest updates and insights on JPMorgan Chase & stock.
JPMorgan Chase & Co. reports developments across a global financial services franchise operating under the J.P. Morgan and Chase brands. News commonly covers investment banking, consumer and small-business banking, commercial banking, financial transaction processing, asset management, and wealth-related services for corporate, institutional, government, nonprofit, commercial real estate and retail customers.
Company updates also include Chase product changes such as Secure Banking, quarterly reporting, commercial banking programs, philanthropic workforce initiatives, and strategic partnerships. Asset-management news includes real estate and timberland investment activity through J.P. Morgan Asset Management and Campbell Global, while broader corporate announcements cover client services, community investment and brand partnerships.
JPMorgan Chase Financial Company LLC has declared a quarterly coupon payment for its Alerian MLP Index ETN (AMJB). The notes, due January 28, 2044, will pay a coupon amount of $0.4836 per note with a current yield of 6.3%. The payment schedule includes an ex-date and record date of May 29, 2025, with the payment to be distributed on June 6, 2025. The notes are senior, unsecured obligations of JPMorgan Chase Financial Company LLC and are fully guaranteed by JPMorgan Chase & Co.
JPMorgan Chase (NYSE: JPM) has announced its schedule for 2026 quarterly earnings conference calls. The financial results will be released at 6:45 a.m. (Eastern) followed by conference calls at 8:30 a.m. (Eastern) on the following dates:
- First-quarter: Tuesday, April 14, 2026
- Second-quarter: Tuesday, July 14, 2026
- Third-quarter: Tuesday, October 13, 2026
- Fourth-quarter: Thursday, January 14, 2027
Live audio webcasts and presentation slides will be available on the company's website. As of March 31, 2025, JPMorgan Chase had $4.4 trillion in assets and $351 billion in stockholders' equity.
JPMorgan Chase (NYSE: JPM) has announced a quarterly dividend declaration for its common stock shareholders. As of March 31, 2025, the financial services giant reported $4.4 trillion in assets and $351 billion in stockholders' equity. JPMorgan Chase maintains a leading position in investment banking, consumer and small business financial services, commercial banking, financial transaction processing, and asset management, serving millions of U.S. customers and prominent global clients under the J.P. Morgan and Chase brands.
J.P. Morgan Life Sciences Private Capital has appointed Dr. Dashyant Dhanak as Venture Partner. Dr. Dhanak brings over 30 years of pharmaceutical R&D experience, most recently serving as Chief Scientific Officer at Deciphera Pharmaceuticals until its $2.4 billion acquisition by Ono Pharmaceuticals in 2024. His previous roles include CSO at Incyte, where he oversaw 15+ IND applications, VP and Global Head of Discovery Sciences at Johnson & Johnson's Janssen, and 25 years at GlaxoSmithKline. Dr. Dhanak will leverage his scientific and operational expertise to build and grow companies within J.P. Morgan's life sciences venture and growth equity division.
JPMorgan Chase (NYSE: JPM) has announced the declaration of dividends for its Series II and OO preferred stock. The financial services giant continues to demonstrate its strong market position with $4.4 trillion in assets and $351 billion in stockholders' equity as of March 31, 2025. JPMorgan Chase maintains its leadership in investment banking, consumer and small business financial services, commercial banking, financial transaction processing, and asset management, serving millions of U.S. customers and prominent global clients under the J.P. Morgan and Chase brands.